TW200907064A - Rapid serotypes K1/K2 test for klebsiella pneumoniae virulent stains - Google Patents
Rapid serotypes K1/K2 test for klebsiella pneumoniae virulent stains Download PDFInfo
- Publication number
- TW200907064A TW200907064A TW96129626A TW96129626A TW200907064A TW 200907064 A TW200907064 A TW 200907064A TW 96129626 A TW96129626 A TW 96129626A TW 96129626 A TW96129626 A TW 96129626A TW 200907064 A TW200907064 A TW 200907064A
- Authority
- TW
- Taiwan
- Prior art keywords
- english
- chinese
- name
- test
- strain
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
200907064 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種克雷伯氏肺炎桿菌毒性菌株K1/K2快速檢驗劑。 【先前技術】 克雷伯氏肺炎湖是革蘭氏陰性的桿g,隸>1於腸内g科,為-重 要的伺機性感染的病原菌。近2〇年來,一種新型的侵襲性克雷伯氏肺 (、 炎桿菌感染逐漸躍升為—個全球性輯興重要社區感染症。克雷伯氏 肺炎桿g引起的化膿性絲症、狂症以及相當比率域染,在 台灣它在革蘭氏陰性桿H巾居第二位。台灣的肝麟百分之八十由克 雷伯氏肺炎桿菌引起’以社區感染為主,非—般之院内感染,病程發 展急速並可能併發眼内炎而導致失明。流行病學分析最常發生在台灣 的血清型K1&K2二型’該二型菌株毒性最強,最容易轉移到眼球造 成嚴重的眼内炎’須將眼球摘除方能保命。目前台灣已有超過7〇例因 C 克氏菌肝膿癌造成終身眼盲的病例。_外的文獻皆指出嚴重的併發 症如眼内炎等之發生皆在克氏菌化膿性肝膿癌形成後 48-72小時之内 發生’因此臨床上若能及早鐘定出此二種毒性株,即刻更改治療方針, 施打較昂貴㈣三帶馳子帛素可驗_炎的_發生。 克氏菌所引起的化膿性肝膿癌為一新興的感染症,目前除了盛行於 亞洲國家及地區之外’歐鱗國亦_有相_文獻報導。而相關的 研九重點集巾在以分子生物學的方法找雜病@子,在以致病因子來 做聚合酶連鎖反應(polymerasechain咖如,pcR),以作為快速診斷 200907064 的方法,目前台灣大學的研究團隊雜找到_基因用來做pcR,但 僅月b測出ΚΙ ®株紅2母性菌株則無法湖,spCR的方法最快需 要準備天的時間’同B寸需要具備昂責的儀器及純熟的技術,且工作 煩殯’必須請專人操作。 .發明内容】 本發明之目社要是亟欲解決早期驗速鑑定克氏頻 及K2型之 毒性菌株以便能即 時提供私床醫師-個準確的答案以便及時治療化膿性肝膿癌所帶來 的併紐的問題。_外的文獻皆指出嚴重的併發症如眼内炎等之發 生白在克氏菌化膿性肝膿瘍形成後48_了2小時之内發生,因此如能在 極短的日年間内利用克氏菌毒性菌株kl/k2快速檢驗劑,於5分鐘内即 可測知該菌是否為毒性菌株,在臨床診斷及治療上將會得到重大突 破。 本發明為利用免疫色層分析(immunochromatogaphic test,ICT)之方法研 發克雷伯氏菌K1及K2型之毒性菌株之快速檢驗。 是以’本發明係關於一種克雷伯氏肺炎桿菌毒性菌株K1/K2的檢驗試 劑’其特徵包括一載體其上固定抗雷克伯氏肺炎桿菌毒性菌株K1/K2 200907064 本發明檢驗試劑中載體包括但不限於係硝酸纖維膜。為有利檢體流 動’載體可黏附於吸水塾片。 本發明檢驗試劑中標記物可顯示抗體與檢體之反應,該標記物包括但 不限於膠體金。 本發明檢驗試劑中抗體為任何動物對克雷伯氏菌K1及K2型毒性菌株之 抗體,其可與膠體金共軛產生共軛物,於較佳具體實施例為小鼠_a_kpl 膠體金共扼物(CGC)或小鼠-a-kp2膠體金共輛物。 本發明檢驗試劑中膠體金與抗體已結合並塗附於一體可擴散载體,形 成一膠體墊片。該膠體金墊片一面可黏附於載體,其另一面可黏附於 檢體墊片。 本發明係關於一種檢測克雷伯是肺炎桿菌毒性株K1/K2之方法,包括(a) 提供一檢體,及(b)將該檢體加入本發明之檢測試劑,及(c)觀察抗體與 檢體是否有聚集反應。 於本發明方法中,檢體係克雷伯氏肺炎桿菌毒性菌株K1或K2,會於遇 到抗體處形成一條實線。 於本發明方法中,檢驗試劑包括一控制線,用以表示試劑運作正常。 本發明方法,可用於任何包括檢體,但不限於臨床肝膿瘍檢體、腦脊 200907064 髓液或尿液檢測。 【實施方式】 實例1: 本發明為利用免疫色層分析(immunochromatogaphic test, ICT)之方法 研發克雷伯氏菌K1及K2型之毒性菌株之快速檢驗,其步驟如下: (一)、克雷伯氏菌Κ1及Κ2型之毒性菌株之抗血清的製備:以低劑量 之Κ1及Κ2型之毒性菌株在小鼠身上發免疫反應,同時加入二級抗體: 山羊-α-小鼠-IgG-HRP(Goat-a-mouse-IgG-HRP)以酵素免疫分析法 (enzyme-linked immunosorbent assay, ELISA)測定其效價,並將所得之抗 體以蛋白質A色層分析純化。 (一) 、喷膜及乾燥:將純化後的抗血清(小鼠_a_kpi及小鼠_a_kp2)稀 釋以噴膜機後嘴量固定至硝酸纖維膜(NC膜,長度為3〇cm),固定後將 置於恆溫恆濕無塵室内乾燥24小時後進行阻斷(bi〇cking)製程作業。 (二) 、膠體金的製備:取適量之抗血清抗體和膠體金(25nm)進行反 應結合及濃縮。將製備好的小鼠_a_kpi CGC及小鼠-a-kp2 CGC,以噴 量3.〇4/Cm以喷膜機固定在材質為玻璃纖維膠體金墊片上,恆溫恆濕箱 内以TEMP=37t:、RH=5%、乾燥30 分鐘。 (四)、試劑组裝作業:將硝酸纖維膜保護層撕下(圖一),黏貼硝 酸纖維膜(位置1),用手指指腹將硝’酸纖維膜確實壓合,確保頌酸纖維 膜黏貼牢固。再將吸水墊片保護層撕下,黏貼吸水墊片(位置2),用手 指指腹將Top pad壓合,確保Top pad黏貼牢固。確認Top pad上緣與 200907064 塑膠底卡上緣㈣。郷體金维置3)表_賴層撕下, 將裁切好的频金墊片沿著檢體墊片無處之保護層上緣黏貼。用手 指指腹將賴金料壓合,確轉體金墊片無牢固。輕麵金塾 片與雜纖維膜有重疊2±1職。最後撕下檢體糾保護層,將裁好的 檢體塾片沿歸底卡下緣對齊貼合(位置彳),手指指腹確實壓合。 霉認檢體墊片與膠體金墊片有重疊5±2mm。 將上述組裝㈣栽卡,賴紙裁城_麟條3細遍如的寬 度’ speed=6G進行裁切’裁切好後組裝試紙條至觸卡内,最後以銘 鉑袋以卧式包裝機包裝。 實例2 : 1、 將肝膿躲體以生理食躲稀釋拌㈣為彳铜之標本,(標本若為腦 ㈣液、尿液或其他體液則可不必稀釋,標本若為已培養好之克氏菌, 則先挑取2-3個菌落用生理食鹽水拌勻即可)。 2、 將試劑之包裝紙打開置於桌上’將待測之標本以微量吸管吸取丄滴 待測之標本滴入標本測試區(S-Weu)。 3、 再以《吸管娜本觸__祕純如却一油㈣3 滴待測之標本狀標本職區(S_well),3_5健_可判讀。 4、 判讀的準則如下: ⑴.若只有-雜紅色的線條出現在c帥騰ye。咖uine), 表示本試継作正常’但_試之標本並不是克氏菌,即使為克氏菌 亦非為毒性最強之K1或K2型菌株。 200907064 ⑵.若·上出現二«紅色猶條,—條㈣在c邮㈣另 外-條出現在i區(職e)或2區似㈣,即可判定簡株為Ki或 K2型菌株。 實例3: 挑取三種不同血清型(包細,K2及咖微2)的菌株測試結果:第 二圖中左側之試劑顯示為跡Κ1/Κ2型菌株,中側之試劑顯示為幻型 菌株,右側之試麵福K2型g株。本·已⑽統之血清分型法作 對照檢驗,結果並未發現與其他Η種不同血清型_株發生交又反應 (crossreaction),顯示本試劑之特異性(specificity)極高。 【圖式簡單說明】 圖一顯示試劑組裝之順序。 S —頁示—種不同血清型(包括幻,^ &n〇n_K1/K2)的菌株測試結果。 【主要元件符號說明】 1硝酸纖維膜 2吸水墊片 3膠體金墊片 4檢體墊片200907064 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a rapid test agent for Kjb Klebsiella virulent strain K1/K2. [Prior Art] Krebs pneumonia lake is a Gram-negative rod g, which is a pathogen of an opportunistic infection in the gut of the intestine. In the past two years, a new type of invasive Krebs' lung (the inflammatory infection has gradually increased to a global community-recovery important community infection. Klebsi's pneumonia g caused by suppurative silk disease, madness And a considerable ratio of domain dyeing, in Taiwan, it ranks second in the Gram-negative rod H. Eighty percent of Taiwan's liver lining is caused by Klebsiella pneumoniae's community-based infection, non-like In-hospital infection, rapid development of the disease and may be accompanied by endophthalmitis leading to blindness. Epidemiological analysis most commonly occurs in Taiwan's serotype K1 & K2 type 2 'The second type of strain is the most toxic, most likely to transfer to the eye to cause serious eyes Endophthalmia must be removed from the eyeball to save life. At present, there are more than 7 cases of life-long blindness caused by C. comatus liver pus cancer in Taiwan. The external literature points out serious complications such as endophthalmitis. The occurrence occurs within 48-72 hours after the formation of Klebsiella purulent hepatic sputum cancer. Therefore, if the two virulent strains are determined early in clinical practice, the treatment policy is changed immediately, and the application is more expensive.帛素 can be tested _ inflammation _ occurs. Suppurative liver and sputum cancer caused by Klebsiella is an emerging infectious disease. At present, in addition to prevailing in Asian countries and regions, 'European countries also have _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ The method of learning to find miscellaneous disease @子, in the case of the cause of the polymerase chain reaction (polymerasechain coffee, such as pcR), as a rapid diagnosis of 200907064 method, the current research team of Taiwan University found _ gene used to do pcR However, only the monthly b measured ΚΙ ® plant red 2 mother strain can not be lake, spCR method needs to prepare for the fastest time 'with B inch need to have the instrument and skillful technology, and work irritated 'must please Specialized operation. SUMMARY OF THE INVENTION The object of the present invention is to solve the early test speed identification of the K-frequency and K2 type of virulent strain so that the private bed doctor can be provided immediately - an accurate answer for timely treatment of suppurative hepatic carcinoma The problems brought by the new _. The external literature pointed out that serious complications such as endophthalmitis occur within 48 hours after the formation of Klebsiella purulent hepatic abscess, so if In the short day-to-day period, the K. pneumoniae strain kl/k2 rapid test agent can be used to detect whether the bacteria is a virulent strain within 5 minutes, and a major breakthrough will be obtained in clinical diagnosis and treatment. A method for the development of a virulence strain of Klebsiella K1 and K2 by the method of immunochromatogaphic test (ICT). The invention relates to a test reagent for a Klebsiella pneumoniae strain K1/K2. 'Characteristics comprising a carrier on which a K. pneumoniae virulence strain K1/K2 200907064 is immobilized. The carrier of the test reagent of the present invention includes, but is not limited to, a nitrocellulose membrane. For the favorable sample flow, the carrier can adhere to the sputum sheet. The label in the assay reagent of the present invention can show the reaction of the antibody with the sample, including but not limited to colloidal gold. The antibody in the test reagent of the present invention is an antibody against any K. cholerae strain K1 and K2 toxic strain, which can be conjugated with colloidal gold to produce a conjugate. In a preferred embodiment, the mouse _a_kpl colloidal gold Sputum (CGC) or mouse-a-kp2 colloidal gold co-host. In the test reagent of the present invention, the colloidal gold and the antibody are combined and coated on the integral diffusible carrier to form a colloidal gasket. The colloidal gold gasket can be adhered to the carrier on one side and adhered to the specimen spacer on the other side. The present invention relates to a method for detecting Krebs is a virulent strain K1/K2 of Klebsiella pneumoniae, comprising (a) providing a sample, and (b) adding the sample to the detection reagent of the present invention, and (c) observing the antibody Whether there is an aggregation reaction with the specimen. In the method of the present invention, the test system Klebsiella pneumoniae strain K1 or K2 forms a solid line at the encounter of the antibody. In the method of the present invention, the test reagent includes a control line to indicate that the reagent is functioning properly. The method of the present invention can be used for any test including, but not limited to, clinical liver and abscess, cerebral ridge 200907064 myeloid or urine test. [Examples] Example 1: The present invention is a rapid test for the development of a virulence strain of Klebsiella K1 and K2 by immunochromatogaphic test (ICT), the steps of which are as follows: (1), Cray Preparation of antiserum against virulence strains of Burdock Κ1 and Κ2: Immunization in mice with low doses of virulence strains of Κ1 and Κ2, and addition of secondary antibody: goat-α-mouse-IgG- HRP (Goat-a-mouse-IgG-HRP) was assayed for its titer by enzyme-linked immunosorbent assay (ELISA), and the resulting antibody was purified by protein A chromatography. (1) Spray film and drying: The purified antiserum (mouse _a_kpi and mouse _a_kp2) was diluted to a nitrocellulose membrane (NC membrane, length 3 〇 cm) after the film spray machine was diluted. After being fixed, it will be placed in a constant temperature and humidity clean room for 24 hours and then subjected to a blocking operation. (B), preparation of colloidal gold: appropriate amount of anti-serum antibody and colloidal gold (25nm) for reaction binding and concentration. The prepared mouse _a_kpi CGC and mouse-a-kp2 CGC were fixed on a glass fiber colloidal gold gasket with a spray volume of 3.〇4/cm by a spray film machine, and TEMP was used in a constant temperature and humidity chamber. =37t:, RH = 5%, dry for 30 minutes. (4) Reagent assembly operation: tear off the protective layer of nitrocellulose membrane (Fig. 1), stick the nitrocellulose membrane (position 1), and press the nitric acid membrane with finger to the abdomen to ensure the tannic acid fiber membrane. Stick firmly. Then peel off the protective layer of the absorbent pad, stick the absorbent pad (position 2), and press the Top pad with your fingertips to ensure that the Top pad is firmly attached. Confirm the top edge of the Top pad and the upper edge of the 200907064 plastic bottom card (4). The body of the body is placed 3) The table is peeled off, and the cut frequency gold gasket is pasted along the upper edge of the protective layer where the sample gasket is nowhere. Pressing the fingertips with your fingertips will press the Lai gold material, and it is true that the gold-plated gasket is not strong. The light-faced golden enamel sheet overlaps with the fiber membrane by 2±1. Finally, the specimen is removed from the protective layer, and the cut specimen is aligned along the lower edge of the bottom card (position 彳), and the fingertips are indeed pressed. The mold sample gasket overlaps with the colloidal gold gasket by 5 ± 2 mm. The above assembly (four) will be carded, and the paper will be cut into the city _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Machine packaging. Example 2: 1. The liver pus and the body should be diluted with physiological food (4) as the specimen of bismuth copper. (If the specimen is brain (four) liquid, urine or other body fluid, it may not need to be diluted. If the specimen is cultivated, it can be cultivated. For bacteria, pick up 2-3 colonies and mix well with physiological saline. 2. Open the wrapping paper of the reagent on the table. Draw the specimen to be tested with a micropipette. The specimen to be tested is dropped into the specimen test area (S-Weu). 3, and then "sucking Na Na touch __ secret pure as an oil (four) 3 drops to be tested specimen specimen area (S_well), 3_5 health _ can be read. 4, the criteria for interpretation are as follows: (1). If only - the red line appears in the c handsome ye. Coffee uine), indicating that the test is normal. However, the specimen is not a Krebs, and even K. pertussis is not the most toxic K1 or K2 strain. 200907064 (2). If there are two «red yokes, _ (4) in c post (four) and another - appear in area i (service e) or zone 2 (4), you can determine that the strain is a strain of Ki or K2. Example 3: Picking strains of three different serotypes (packaged, K2 and coffee 2) test results: the reagent on the left side in the second figure is shown as a strain of Κ1/Κ2 type, and the reagent on the middle side is shown as a phantom strain. On the right side, the test surface is K2 type g strain. The serotyping method of this (10) system was used as a control test, and the results did not find cross-reaction with other serotypes of different serotypes, indicating that the specificity of the reagent was extremely high. [Simple description of the diagram] Figure 1 shows the sequence of reagent assembly. S - page shows the results of strain tests for different serotypes (including magic, ^ & n〇n_K1/K2). [Main component symbol description] 1 nitrocellulose membrane 2 absorbent gasket 3 colloidal gold gasket 4 specimen gasket
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW96129626A TWI384075B (en) | 2007-08-10 | 2007-08-10 | Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW96129626A TWI384075B (en) | 2007-08-10 | 2007-08-10 | Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200907064A true TW200907064A (en) | 2009-02-16 |
TWI384075B TWI384075B (en) | 2013-02-01 |
Family
ID=44723282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW96129626A TWI384075B (en) | 2007-08-10 | 2007-08-10 | Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI384075B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110499374A (en) * | 2019-08-12 | 2019-11-26 | 山东农业大学 | A kind of triple PCR primer sets, kit and application detecting Klebsiella Pneumoniae |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI772776B (en) | 2020-04-09 | 2022-08-01 | 美商艾諾斯股份有限公司 | A pneumonia detection device |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW472148B (en) * | 1997-10-18 | 2002-01-11 | Dev Center Biotechnology | Test reagents for detecting at least two objects to be tested in sample comprising novel colloid-antibody mixture and preparation process thereof |
-
2007
- 2007-08-10 TW TW96129626A patent/TWI384075B/en active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110499374A (en) * | 2019-08-12 | 2019-11-26 | 山东农业大学 | A kind of triple PCR primer sets, kit and application detecting Klebsiella Pneumoniae |
CN110499374B (en) * | 2019-08-12 | 2020-07-17 | 山东农业大学 | Triple PCR primer group for detecting Klebsiella pneumoniae, kit and application |
Also Published As
Publication number | Publication date |
---|---|
TWI384075B (en) | 2013-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Muthukrishnan | Multidrug resistant tuberculosis–Diagnostic challenges and its conquering by nanotechnology approach–An overview | |
Choi et al. | Lateral flow assay based on paper–hydrogel hybrid material for sensitive point‐of‐care detection of dengue virus | |
US8222046B2 (en) | Amplification for solid phase immunoassay | |
Gupta et al. | Recent advances in gold nanoparticle-based lateral flow immunoassay for the detection of bacterial infection | |
CN108169492A (en) | It is a kind of to be used to detect colloidal gold immuno-chromatography test paper strip of bovine rota and its preparation method and application | |
JP6150559B2 (en) | Detection method of Mycoplasma pneumonia | |
Zou et al. | Magneto-plamonic nanoparticles enhanced surface plasmon resonance TB sensor based on recombinant gold binding antibody | |
Ariffin et al. | Lateral flow immunoassay for naked eye detection of Mycobacterium tuberculosis | |
Ghaleb et al. | Assessment of diagnostic techniques of urinary tuberculosis | |
Braga et al. | Entamoeba histolytica and Entamoeba dispar infections as detected by monoclonal antibody in an urban slum in Fortaleza, Northeastern Brazil | |
Esteban et al. | Diagnosis of human trematode infections | |
WO2019241188A1 (en) | Antibody pairs for use in a rapid influenza b diagnostic test | |
TW200907064A (en) | Rapid serotypes K1/K2 test for klebsiella pneumoniae virulent stains | |
Ehara et al. | A novel method for rapid detection of Streptococcus pneumoniae antigen in sputum and its application in adult respiratory tract infections | |
CN104569389A (en) | Kit for typing detection of helicobacter pylori | |
JP4419020B2 (en) | Method for detecting Mycobacterium tuberculosis antigen in body fluid | |
CN102967705A (en) | Kit for classificatory detection of helicobacter pylori | |
Sudha | Tuberculosis diagnosis-an overview to the conventional diagnostic methodology and need for nanodiagnosis | |
CN112334478A (en) | Antibody pairs for rapid influenza a diagnostic tests | |
CN106687813B (en) | IgM sxemiquantitative leptospirosis diagnostic kit | |
TW201142037A (en) | Rapid test reagent for detecting Klebsiella pneumoniae serotypes K1 and used thereof | |
EP1933148B1 (en) | Urinary immunochromatographic multiparameter detection cup | |
AU2020328849A1 (en) | Test system for recognizing legionellae | |
Patel et al. | Nanotechnology in TB Diagnosis | |
Waites et al. | Mycoplasma: immunologic and molecular diagnostic methods |